The National Stock Exchange (NSE) announced on Sunday that it will invest ₹380 crore to construct a multi-speciality hospital and bone marrow transplant (BMT) centre at the Tata Memorial Centre’s (TMC) ACTREC campus in Navi Mumbai.
The upcoming 11-storey NSE Hospital Block, being built by Larsen & Toubro (L&T), will be the largest BMT facility in India, the exchange said in an official statement.
Once operational, the centre is expected to handle around 1.3 lakh OPD visits annually, perform over 600 bone marrow transplants each year, and house 60 beds.
The project, spread across 2.4 lakh sq ft, is being funded under NSE’s Corporate Social Responsibility (CSR) initiative and is scheduled to begin operations by July 2027.
The NSE Foundation has partnered with the Tata Memorial Hospital (TMH)-run Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) for the project, which received board approval in March 2023.
“Our aim is to support the healthcare needs of cancer patients and their families, and contribute meaningfully to the fight against cancer in India,” said Ashishkumar Chauhan, MD & CEO of NSE.
TMC Director Sudeep Gupta added that the new facility will fill a critical gap in specialized treatment for cancer patients suffering from comorbidities such as cardiac, renal, or neurological conditions, which currently require referrals to other hospitals.
